These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 9057383)
1. Immunogenicity of Edmonston-Zagreb measles vaccine. Parmar VR; Sood AK; Goyal A; Sharma V; Singh T Indian Pediatr; 1996 Oct; 33(10):845-50. PubMed ID: 9057383 [No Abstract] [Full Text] [Related]
2. Immunogenicity of standard dose Edmonston-Zagreb measles vaccine in highland Papua New Guinean children from four months of age. Rogers S; Sanders RC; Alpers MP J Trop Med Hyg; 1991 Apr; 94(2):88-91. PubMed ID: 2023293 [TBL] [Abstract][Full Text] [Related]
4. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL J Infect Dis; 2004 Jan; 189(2):254-7. PubMed ID: 14722890 [TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241 [TBL] [Abstract][Full Text] [Related]
6. Rural Kenya: measles during pregnancy and early infancy. Arya SC; Agarwal N J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147 [No Abstract] [Full Text] [Related]
7. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial. Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911 [TBL] [Abstract][Full Text] [Related]
8. Passive transmission and persistence of naturally acquired or vaccine-induced maternal antibodies against measles in newborns. Leuridan E; Van Damme P Vaccine; 2007 Aug; 25(34):6296-304. PubMed ID: 17629601 [TBL] [Abstract][Full Text] [Related]
9. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. Naniche D; Garenne M; Rae C; Manchester M; Buchta R; Brodine SK; Oldstone MB J Infect Dis; 2004 Oct; 190(8):1387-95. PubMed ID: 15378430 [TBL] [Abstract][Full Text] [Related]
10. [Anti-measles antibodies in the first 2 years of life]. Echevarría JM; Sainz C; Montón JL; González F; Crespo E; Morales E; Cortés M; Taracena B; Nájera R An Esp Pediatr; 1984 Jun; 20(9):847-53. PubMed ID: 6486579 [TBL] [Abstract][Full Text] [Related]
11. Girls may have lower levels of maternal measles antibodies and higher risk of subclinical measles infection before the age of measles vaccination. Martins C; Bale C; Garly ML; Rodrigues A; Lisse IM; Andersen A; Eriksson M; Benn CS; Whittle H; Aaby P Vaccine; 2009 Aug; 27(38):5220-5. PubMed ID: 19596409 [TBL] [Abstract][Full Text] [Related]
12. Population immunity to measles in the United States, 1999. Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096 [TBL] [Abstract][Full Text] [Related]
14. Immunological response to primary and secondary measles vaccination among school-age children in Malatya, Turkey. Durmaz R; Yakinci C; Köroğlu M; Tekerekoğlu MS J Trop Pediatr; 1998 Apr; 44(2):120. PubMed ID: 9604604 [No Abstract] [Full Text] [Related]
15. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bennett JV; Fernandez de Castro J; Valdespino-Gomez JL; Garcia-Garcia Mde L; Islas-Romero R; Echaniz-Aviles G; Jimenez-Corona A; Sepulveda-Amor J Bull World Health Organ; 2002; 80(10):806-12. PubMed ID: 12471401 [TBL] [Abstract][Full Text] [Related]
16. [Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life]. Hohendahl J; Peters N; Hüttermann U; Rieger C Klin Padiatr; 2006; 218(4):213-20. PubMed ID: 16819702 [TBL] [Abstract][Full Text] [Related]
17. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. Gans H; Yasukawa L; Rinki M; DeHovitz R; Forghani B; Beeler J; Audet S; Maldonado Y; Arvin AM J Infect Dis; 2001 Oct; 184(7):817-26. PubMed ID: 11528592 [TBL] [Abstract][Full Text] [Related]
18. [Effect of myelopeptide 2 on the immunization of guinea pigs with live measles vaccine]. Liashenko VA; Mikhaĭlova AA; Aleksander SK; Iuminova NV; Fonina LA; Kolyshkin VM Vopr Virusol; 2004; 49(2):18-20. PubMed ID: 15106378 [TBL] [Abstract][Full Text] [Related]
19. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination. Bertley FM; Ibrahim SA; Libman M; Ward BJ Vaccine; 2004 Dec; 23(4):444-9. PubMed ID: 15530692 [TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. Martins CL; Garly ML; Balé C; Rodrigues A; Ravn H; Whittle HC; Lisse IM; Aaby P BMJ; 2008 Jul; 337():a661. PubMed ID: 18653640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]